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 Introduction 
 Anxiety disorders are the most prevalent mental dis-
orders not only of adulthood but also of childhood and 
adolescence  [1, 2] . Trait anxiety seems to have increased 
greatly  [3] and new research shows that childhood anxiety 
disorders are important risk factors for the development 
of mental disorders in adulthood, including anxiety dis-
orders, depression and substance abuse  [4–6] . The devel-
opment and dissemination of efﬁ cacious treatments are, 
therefore, essential. 
 Clinical research on psychotherapy for anxiety disor-
ders in children has advanced considerably in recent 
years. Different research groups have conducted several 
randomized controlled trials (RCTs) and substantial 
progress has been made in treating anxiety disorders in 
children and adolescents. However, these studies need to 
be summarized and discussed. 
 Meta-analyses represent an empirical approach to 
evaluating psychotherapy research. For a review of 
strengths and limitations of meta-analyses, see Sensky  [7] . 
First meta-analyses have been published examining the 
efﬁ cacy of child and adolescent psychotherapies in gen-
eral; yet further speciﬁ c analyses of anxiety disorders were 
not the aim of these studies. Casey and Berman  [8] re-
ported an overall outcome effect size of 0.74 for child 
psychotherapy (n = 75; studies published from 1952 to 
1983) and an average treatment versus control effect size 
of 1.16 for phobias (n = 9 studies). Weisz et al.  [9] aggre-
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 Abstract 
 Background: The present study compared the effi cacy of 
psychotherapy for childhood anxiety disorders (exclud-
ing trials solely treating post-traumatic stress disorder 
or obsessive-compulsive disorder).  Methods: The meta-
analysis included studies that met the basic CONSORT 
(consolidated standards of reporting trials) criteria. Sev-
eral outcome variables (e.g. effect sizes, percentage of 
recovery) were analyzed using completer and intent-to-
treat analyses during post-treatment and follow-up as-
sessment. Twenty-four studies published by March 2005 
were included in this meta-analysis.  Results: In all the 
included studies, the active treatment condition was cog-
nitive-behavioral. The overall mean effect of treatment 
was 0.86. No differences in outcome were found be-
tween individual and group treatments or child- and fam-
ily-focused treatments. Follow-up data demonstrated 
that treatment gains were maintained up to several years 
after treatment.  Conclusions : These fi ndings provide ev-
idence that anxiety disorders in children can be treated 
effi caciously. The gathered data support the clinical util-
ity of cognitive-behavioral therapy in this regard. Ran-
domized controlled trial studies investigating treatments 
other than cognitive-behavioral therapy are missing. 
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gated the effects of 39 treatment-control comparisons and 
reported a mean overall effect size of 0.79 for child psy-
chotherapy (n = 163; studies published from 1958 to 
1984) and a mean effect size of 0.74 for phobias and anx-
iety. 
 A meta-analysis by Weisz et al.  [10] produced an effect 
size of 0.60 (n = 16 studies) for phobias and anxiety and 
an overall effect size of 0.54 (n = 150; studies published 
from 1967 to 1993). An examination of the different types 
of therapies used in these studies showed that most were 
behavioral therapies. In addition, effects were more ro-
bust for behavioral than nonbehavioral treatments. 
 A major limitation of previously published meta-anal-
yses is the inclusion of studies which did not require the 
establishment of diagnoses on the basis of DSM or ICD 
criteria. Furthermore, these meta-analyses did not in-
clude studies published after 1993. However, in the last 
10 years, substantial progress has been made regarding 
psychotherapy research in the area of childhood anxiety 
disorders. 
 In order to improve the quality of reports using RCTs 
and to comprehend the results of RCTs, the consolidat-
ed standards of reporting trials (CONSORT) were de-
veloped. The CONSORT criteria checklist contains 
 recommendations for four stages of a trial (enrolment, 
intervention allocation, follow-up, and analysis). Ac-
cording to current guidelines  [11, 12] (http://www.con-
sort-statement.org) and the fact that in recent years, sev-
eral methodologically rigorous child and adolescent anx-
iety treatment outcome studies have been completed, 
the purpose of this paper was to provide a comprehen-
sive meta-analysis of child and adolescent psychothera-
py outcomes for anxiety disorders, including only stud-
ies that meet basic methodological criteria. Just recent-
ly, an extensive review by Compton et al. [13] summarized 
RCTs on anxiety and depression and concluded that 
cognitive-behavioral therapy (CBT) is currently the 
treatment of choice for anxiety and depression in chil-
dren and adolescents  [see also 14] . However, this review 
did not include any statistical analyses summarizing the 
results of these studies and did not analyze different 
treatment settings, which could be relevant regarding 
treatment outcome. Therefore, the present study means 
to close this gap and summarize the overall effect sizes 
of recently published RCTs, including analyses of dif-
ferent treatment settings in regard to treatment out-
come. The data are aggregated from published studies 
in the ﬁ eld and multiple outcome variables are reported 
including effect sizes of several treatment settings (e.g. 
individual vs. group treatment or child- vs. family-fo-
cused treatment), recovery rates (both completer and 
intent-to-treat), sustained recovery rates and the results 
of follow-up assessments. 
 Method 
 Literature Search 
 In this meta-analysis, we included only published, peer-re-
viewed psychotherapy outcome studies in English and German. 
The literature search was conducted in PsycINFO and Medline 
(= PubMed) using the following key words: ‘childhood’, ‘children’, 
‘anxiety disorders’, ‘speciﬁ c phobia’, ‘simple phobia’, ‘social pho-
bia’, ‘panic disorder’, ‘separation anxiety disorder’, ‘generalized 
anxiety disorder’, ‘overanxious disorder’, ‘avoidant disorder’, ‘ther-
apy’, ‘outcome’, and ‘treatment’. We also included psychotherapy 
studies that were listed in the reference sections of the papers we 
collected after the initial computer search and conducted an Inter-
net search. This literature search produced a total of 36 treatment 
studies. Obsessive-compulsive disorder (OCD) and post-traumatic 
stress disorder (PTSD) will not be addressed in this meta-analysis 
because both basic research and psychotherapy research of these 
two disorders differ substantially from childhood anxiety disorders 
mentioned above. In this regard, there is an ongoing discussion 
whether OCD should even be assigned to anxiety disorders (see 
ICD-10). For separate reviews of psychotherapy research in OCD 
and PTSD, see Cartwright-Hatton et al.  [14] , Cohen et al.  [15] , 
Franklin et al.  [16] and Simons et al.  [70] . 
 Inclusion Criteria 
 All studies included in this meta-analysis were required to have 
investigated the efﬁ cacy of a speciﬁ c treatment for anxiety disor-
ders in children against a control condition or alternative credible 
psychotherapeutic treatment. Participants (i.e., the children who 
were treated) had to have met DSM or ICD diagnostic criteria for 
a principal anxiety disorder, and participants had to have been 
randomly assigned to either treatment or control conditions (i.e., 
an RCT). In accordance with the CONSORT guidelines, the au-
thors of the studies were required to have written a standard treat-
ment protocol. In order to facilitate computation of effect sizes, 
studies were included only if they reported means and standard 
deviations of the outcome measures as well as sample sizes at each 
assessment time point. We excluded studies in which treatment 
groups had fewer than 10 patients (lack of power), single case stud-
ies, subclinical cases and psychopharmacological studies. Studies 
had to have been published by March 2005. All decisions were 
made a priori, before examining any individual studies. These sev-
eral steps produced a pool of 24 studies for further analyses. An 
overview of all the studies is in Appendix 1. The treatment orien-
tation of the excluded studies was primarily CBT, except the chart 
review of Target and Fonagy  [18] , which involved a psychody-
namic approach. 
 Effect Size  
 The effect size (Cohen’s d) is an index of the size and direction 
of treatment effects. Cohen  [19] suggests that an effect size of 0.20 
may be considered a small effect, 0.50 a medium effect, and 0.80 
a large effect. 
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 We computed different effect sizes for both treatment and con-
trol conditions including a global effect size and separate effect 
sizes for the three most commonly used outcome measures (see 
below). Effect sizes were calculated for pre-/post-treatment and for 
pre-follow-up assessments. Within each study, effect size values 
were averaged across all outcome variables to an overall effect size 
(one effect size per study). In a second step, these effect sizes were 
averaged across all studies (global effect size). Speciﬁ c effect sizes 
were calculated separately for the most commonly used measure-
ments, i.e. Revised Children’s Manifest Anxiety Scale (RCMAS), 
Fear Survey Schedule for Children-Revised (FSSC-R), and Chil-
dren’s Depression Inventory (CDI) within each study and then av-
eraged across all studies. In addition, 95% conﬁ dence intervals were 
computed for the effect sizes of each category. When the associated 
conﬁ dence intervals do not include 0, this indicates that the aver-
age effect size is signiﬁ cantly greater than zero at p  ! 0.05. Q sta-
tistic was calculated to determine whether the effect size data from 
the studies are homogeneous. If the studies share a common effect 
size, the value of Q will be nonsigniﬁ cant. Fail-safe number statis-
tics were calculated to check the robustness of the ﬁ ndings and 
whether signiﬁ cant mean effect sizes might have been inﬂ ated by a 
publication bias  [20] . The fail-safe number informs about the num-
ber of ﬁ le drawer studies required to bring the mean effect size down 
to a deﬁ ned level. Orwin  [21] adopted Rosenthal’s formula for 
probabilities to effect sizes d: n fs  = [n total  (mean d  – d crit )]/d crit.  
 In additional analyses, we distinguished between child- and 
family-focused treatments. Child-focused treatment was deﬁ ned as 
the treatment which focuses on the children and in which the par-
ents are either not included at all or minimally involved (i.e., in 
three sessions or fewer). Family-focused treatment was deﬁ ned as 
the treatment in which parents are actively involved in the treat-
ment process for more than three sessions, the nature and extent of 
parental involvement being clearly described in the treatment pro-
cedure section of the study. 
 Recovery  
 Percent recovered is an essential index of a clinically signiﬁ cant 
change. However, most of the studies reported recovery rates based 
on the percentage recovered compared to those who completed 
treatment rather than those who entered treatment (i.e., intent-to-
treat). Intent-to-treat analyses produce a more conservative esti-
mate of recovery by answering the question: ‘Of those patients who 
entered in and began treatment, what percentage is likely to re-
cover?’ We will report recovery rates for both completer and intent-
to-treat analyses. 
 Follow-Up Data  
 Follow-up data provide an accurate picture of the efﬁ cacy of 
treatment and its lasting effects. 
 Measures 
 In order to establish diagnoses before and after treatment and 
at follow-up and to determine diagnostic recovery, most studies 
used the Anxiety Disorders Interview Schedule for Children (ADIS) 
 [22] . The ADIS is a structured diagnostic interview consistent with 
the DSM-IV criteria. It assesses child functioning (anxiety, mood, 
and externalizing disorders) in separate interviews: one with the 
child and one with the parents. The ADIS contains a Clinician Se-
verity Rating, a scale ranging from 0 (absent) to 8 (very severe) that 
represents the degree of symptom severity and interference of di-
agnosis assigned by the interviewer based on clinical information 
provided by the interview. The interview has good interrater reli-
ability for the child and the parent interview, adequate test-retest 
reliability  [23] , and is sensitive to treatment effects in studies with 
youths with anxiety disorders  [24] . 
 Child Measures 
 The RCMAS  [25] measures chronic anxiety and is one of the 
most frequently used anxiety self-report measures for children. The 
RCMAS consists of 37 items, each one rated as true or false. There 
has been extensive work supporting the RCMAS’s validity and re-
liability  [25] . Signiﬁ cant correlations have been found between 
 RCMAS scores and other self-report measures of anxiety and re-
lated constructs such as depression  [26] . 
 The FSSC-R consists of 80 items and assesses speciﬁ c fears in 
children  [27] . The child rates his or her level of fear on a three-point 
Likert scale. Ollendick  [27] reported solid internal consistency and 
adequate test-retest reliability. 
 The CDI consists of 27 items and assesses cognitive, affective, 
and behavioral symptoms of depression. For each item, children 
are given three choices from which they select the one which best 
describes themselves over the past 2 weeks. The CDI has good in-
ternal consistency, moderate test-retest reliability  [28] and corre-
lates in the expected direction with measures of related constructs 
such as self-esteem, negative cognitive attributes, and hopelessness 
 [29] . 
 Procedure 
 We assessed the following major variables from each study: 
sample size, means and standard deviations of outcome measures, 
percentage of children who completed treatment, pre-/post-treat-
ment and treatment-control effect sizes, and percentage of children 
who recovered after treatment, both for those who entered (intent-
to-treat) and for those who completed treatment. For follow-up, we 
assessed the same variables provided that such data were avail-
able. 
 Effect Size Calculation 
 The pre-/post-treatment and pre-follow-up effect sizes were cal-
culated as follows: 
   
1 2
2 2
1 1 2 2
1 2
1 1
2
t t
t t t t
t t
M M
N SD N SD
N N

  
 
esd 
 where  M is the mean of the measurement,  t1 represents the pretreat-
ment assessment,  t2 represents the post-treatment or follow-up as-
sessment,  N is the sample size, and  SD the standard deviation 
 [30] . 
 To investigate the treatment-control effect size we used the fol-
lowing formula: 
   TGpost CGpost TGpre CGpre
es
pooledpre pooledpre
M M M M
d
SD SD
           
      
 where  M is the mean of the measurement,  TG represents the treat-
ment group,  CG represents the control group, and  SD  pooledpre  is the 
pooled within-group standard deviation. 
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 Results 
 Data from 24 clinical trials were included in this meta-
analysis. In all 24 studies, the active treatment condition 
was cognitive-behavioral. Twelve studies included indi-
vidual treatment and ﬁ fteen included group therapy. 
Seventeen studies included child-focused treatment and 
14 included family-focused treatment. Sixteen studies 
had a waiting list control condition; the remaining in-
cluded an alternative therapy as a control condition. The 
length of treatment ranged from 3 to 18 sessions, with an 
average length of 12.3 sessions. The total number of pa-
tients across all studies was 1,275, and the mean age of 
participants was 10.9 years (range: 6–18 years). The vast 
majority of studies evaluated the efﬁ cacy of psychother-
apy in children with anxiety disorders. Only the study of 
Ginsburg and Drake  [31] examined the feasibility and 
effectiveness of a school-based group CBT for anxiety 
disorders with low-income African-American adoles-
cents. The study conducted by Baer and Garland  [32] 
evaluated a CBT program in a community psychiatric 
setting. 
 Interventions Used by the Studies 
 Most programs were designed to target the child’s anx-
iety using a mixture of exposure techniques (90.5%), cog-
nitive restructuring strategies (66.7%), relaxation tech-
niques (52.4%), and positive self-talk (38.1%). In regard 
to parents, the majority of family-focused treatment stud-
ies used the following interventions: teaching parents to 
deal and cope with child anxiety and its related behaviors, 
teaching communication and problem-solving skills, and 
managing the parents’ own anxiety. Interventions used in 
the attention placebo control condition were designed to 
provide the child and the parents with a broad range of 
information about anxiety (education support), but no 
encouragement or instructions were offered to confront 
feared situations  [33–36] . 
 Exclusion Criteria Used by the Studies  1  
 Many studies excluded children with psychotic symp-
toms (72.2%) and mental retardation (50%). Most studies 
(77.8%) excluded children who were currently involved 
in psychosocial or psychopharmacological treatment. 
However, more recent studies  [32, 37–39] did include 
children who were on psychopharmacological medica-
tion, as long as they maintained a constant dosage on the 
same medication throughout the duration of the study. 
 Completion Rates 
 Most children who entered treatment (n = 1,275) com-
pleted it (n = 1,080; 84.7%). Completion rates were 85.8% 
for group treatment, 84.9% for individual therapy, 82.9% 
for family-focused treatment, and 84.9% for child-fo-
cused treatment. Thus, very similar completion rates 
were found across all modes of treatment. 
 Effect Sizes 
 Active Treatment vs. Waiting List (Global and 
Speciﬁ c Effect Sizes) 
 The mean overall pre-/post-treatment effect size across 
all treatments was d = 0.86 (95% CI = 0.69–1.03; n = 24), 
whereas the effect size for the waiting list control group 
was d = 0.13 (95% CI = 0.03–0.24; n = 16). The speciﬁ c 
effect sizes for the three most common treatment out-
come measurements (RCMAS, FSSC-R, and CDI) were 
as follows: pre-/post-treatment effect size in the treatment 
condition was 0.83 (95% CI = 0.64–1.02) for trait anxiety 
(RCMAS) and 0.85 (95% CI = 0.45–1.24) for phobic anx-
iety (FSSC-R). In the control condition, effect sizes were 
0.22 (95% CI = 0.08–0.35; RCMAS) and 0.32 (95% CI = 
0.11–0.54; FSSC-R). Furthermore, symptoms of depres-
sion (CDI) improved signiﬁ cantly (d = 0.70; 95% CI = 
0.54–0.86) in the treatment condition compared to the 
waitlist control condition (d = 0.20; 95% CI = 0.07–0.33). 
The mean overall treatment versus control effect size 
across all active treatments averaged 0.66 (95% CI = 
0.36–0.96) at the post-treatment assessment. The t test 
with independent samples revealed a signiﬁ cant differ-
ence between treatment versus control effect size [t(37) = 
6.92, p = 0.00]. 
 Homogeneity of effect sizes for post-test data was test-
ed. The resulting    2  value was nonsigniﬁ cant [   2 (24) = 
25.08, p = 0.20], indicating that the assumption of homo-
geneity for the post-test effect sizes cannot be rejected. 
 The fail-safe number of this study suggests that 79 ﬁ le 
drawer studies with effect sizes of zero are necessary to 
reduce the effect size of 0.86 to a mean effect size of 0.20. 
To reduce the effect size of 0.86 to a mean effect size of 
0.50, 17 studies of zero effect would be necessary. 
 Follow-Up 
 Of the 24 outcome studies, 16 reported short-term fol-
low-up assessment data. On average, short-term follow-
up assessments occurred 10.4 months after the end of 
treatment. The effect size for pre-follow-up was 1.36 (95% 
  1    The exclusion criteria for each study included in this meta-analysis can be 
requested from the authors. 
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CI = 0.78–1.94; n = 16). There are 3 long-term follow-up 
studies: the 6-year follow-up study by Barrett et al.  [40] , 
the 3.4-year study by Kendall and Southam-Gerow  [41] 
and the 7.4-year study by Kendall et al.  [42] . The long-
term effect size for the study by Kendall and Southam-
Gerow  [41] was 0.61. The effect size for the 6-year follow-
up study of Barrett et al.  [40] was 0.82. Finally, the effect 
size for the 7.4-year follow-up study by Kendall et al.  [42] 
was 1.13 for child report and 1.54 for parent report. 
 Treatment Setting (Global Effect Sizes) 
 Table 1 displays the mean overall pre-/post-treatment 
and pre-follow-up effect sizes for the outcome studies by 
treatment type. Group and individual treatments were 
equally effective in reducing children’s symptoms. The 
mean overall treatment versus control pre-/post-treat-
ment effect sizes were 0.52 (95% CI = 0.04–0.99) for in-
dividual therapy and 0.61 (95% CI = 0.44–0.79) for group 
therapy. The t test with independent samples revealed a 
nonsigniﬁ cant difference [t(11) = 0.33, p = 0.75]. 
 As shown in  table 1 , the pre-/post-treatment effect size 
for child-focused treatments was similar to the effect size 
of treatments involving parents. The mean overall treat-
ment versus control pre-/post-treatment effect sizes were 
0.53 (95% CI = 0.30–0.77) for child-focused therapy and 
0.63 (95% CI = 1.3–0.58) for family-focused therapy. This 
difference was not signiﬁ cant [t(21) = 0.26, p = 0.79]. 
 Placebo Condition vs. Waiting List (Global Effect 
Sizes) 
 We compared waiting list control conditions with ac-
tive, nonspeciﬁ c control conditions, and the pre-/post-
treatment effect sizes were 0.13 (95% CI = 0.03–0.24; 
n = 16) for waiting list and 0.58 (95% CI = –1.6 to 1.3; 
n = 4) for attention placebo control. 
 Percent Recovered 
 Table 2 displays the percentage of patients who recov-
ered from those who completed and those who entered 
treatment. Across all active treatments, 68.9% of children 
who completed therapy no longer met the diagnostic cri-
teria for their principal pretreatment anxiety disorder 
compared to only 12.9% of children who were assigned 
to a waiting list. The t test with independent samples re-
Pre-/
post-treatment
95% CI Follow-up 95% CI
Individual therapy 1.00 (n = 6) 0.80–1.21 1.04 (n = 5) 0.61–1.47
Group therapy 0.97 (n = 10) 0.62–1.32 1.64 (n = 4) –0.84 to 4.11
Child-focused therapy 0.91 (n = 16) 0.73–1.1 1.30 (n = 10) 0.75–1.85
Family-focused therapy 0.83 (n = 10) 0.42–1.25 1.38 (n = 9) 0.44–2.3
Some studies investigated more than one treatment setting.
Table 1. Pre-/post-treatment and follow-up 
effect sizes (d) and 95% conﬁ dence 
intervals for individual vs. group therapy 
and for child-focused vs. family-focused 
therapy
Percent recovered of 
completed
Percent recovered of 
entered (intent-to-treat)
mean 8 SD n mean 8 SD n
Individual treatment 72.1814.48 11 57.3817.42 7
Group treatment 6688.84 12 53.287.36 6
Child-focused treatment 64.1810.46 12 54.4812.95 11
Family-focused treatment 76.987.88 10 65.2814.76 9
All active treatments 68.9811.75 21 55.4813.43 13
Waiting list control group 12.989.8 15 – –
There is a signiﬁ cant difference between the treatment and waiting list control 
groups.
Table 2. Percentage of patients who 
recovered of those who completed or 
entered treatment
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vealed a signiﬁ cant difference between treatment versus 
control group after treatment with respect to children 
without anxiety diagnosis [t(34) = 15.06, p  ! 0.00]. At the 
follow-up assessment, the recovery rate of children who 
completed treatment increased slightly to 72%. 
 Individual and group therapies showed comparable 
recovery rates of 72.1% and 66%, respectively. For the 
intent-to-treat sample, the overall recovery rate after 
treatment was 55.4%. Intent-to-treat recovery rates were 
similar for individual (57.3%) and group (53.2%) therapy. 
Child- and family-focused treatment showed recovery 
rates of 64.1% and 76.9%, respectively. For the intent-to-
treat sample, the recovery rate after treatment for child-
focused treatment was 54.4% and 65.2% for family-fo-
cused treatment. Because of a lack of the majority of treat-
ment studies to report the number of dropouts in the 
waiting list conditions, the intent-to-treat recovery rate 
could not be investigated. 
 Discussion 
 In the present study, we examined 24 RCTs out of a 
pool of 36 treatment outcome studies on anxiety disor-
ders in children and adolescents. The results of the pres-
ent study indicate that treatment produces acute effects, 
which reﬂ ect substantial symptom improvement. The 
current ﬁ ndings are consistent with previous meta-analy-
ses and provide convergent evidence that CBT is effective 
for children with anxiety disorders. 
 The robust effects of therapy are reﬂ ected in the pre-/
post-treatment effect sizes of 0.86 in the treatment and 
0.13 in the waiting list control conditions. Of the children 
included in our study who completed treatment, 68.9% 
recovered to the extent that they no longer met criteria 
for their principal pretreatment anxiety diagnosis. In 
comparison, only 12.9% of waiting list participants recov-
ered. Furthermore, the fail-safe number statistic shows 
that 79 ﬁ le drawer studies with effect sizes of zero are 
needed to reduce this effect size to a mean effect size of 
0.20. 
 Symptom improvements following treatment occurred 
not only for anxiety but also for depression. The treat-
ment versus control effect size was 0.66. Previous meta-
analytic estimates reported similar  [10] or higher pre-/
post-treatment effect sizes  [8, 9] in general child and ado-
lescent psychotherapy. 
 Interestingly, the attention placebo control condition 
reached a pre/post-treatment effect size of 0.58 (n = 4). 
Compared to the overall pre-/post-treatment effect size 
of the active treatment condition (0.86), the effect size for 
the active control condition is quite high. Four studies 
included in our meta-analysis compared their active in-
terventions with an attention placebo control condition 
 [33–36] . However, only the study of Beidel et al.  [33] and 
Muris et al.  [36] used a strict placebo condition consisting 
of study skills, test-taking strategies and emotional disclo-
sure, which led to a signiﬁ cant treatment vs. placebo ef-
fect. The two other studies included psychoeducation on 
anxiety comparable to information given in CBT pro-
grams, which were equally effective as the active treat-
ments. Thus, these results could imply that improvement 
in childhood anxiety disorder can be achieved purely with 
psychoeducation on anxiety, without explicit instructions 
for exposures. This interesting issue requires further in-
vestigation. 
 Treatment outcome studies comparing the efﬁ cacy of 
child-alone therapy to interventions involving both chil-
dren and parents have found conﬂ icting results. As in the 
meta-analysis of Casey and Berman  [8] , we did not ﬁ nd 
a difference between the two types of treatment. The 
mean treatment versus control effect size was 0.53 for 
child-focused therapy and 0.63 for family-focused treat-
ment. To date, there is no clear empirical evidence indi-
cating who might beneﬁ t more from one type of therapy 
over the other. Some data suggest that younger children 
and children with parents who have an anxiety disorder 
themselves may beneﬁ t more from a combined child and 
parent treatment than from a child-alone therapy  [43, 
44] . However, in the study by Barrett et al.  [43] , the rela-
tive superiority of CBT plus family anxiety management 
condition compared to CBT alone at the 12-month post-
treatment assessment disappeared at the 6-year follow-up 
assessment  [40] . Likewise, the results of other studies 
 [45–47] suggest that for some children, a child-alone ap-
proach may be sufﬁ cient for anxiety symptom reduction. 
Further research must examine the role of parental in-
volvement in treatment for children with different anxi-
ety disorders and identify child and family characteristics 
that will enable clinicians to assign anxious children to 
either a child-alone intervention or a combined parent-
child intervention. 
 While earlier studies established the efﬁ cacy of indi-
vidual therapy in treating child anxiety disorders, the re-
sults of a number of recent trials suggest that group treat-
ment may be equally efﬁ cacious  [38, 48] . In the present 
study, the mean effect sizes for group and individual ther-
apy were comparable. These results should nevertheless 
be interpreted with caution. A number of group treatment 
studies in our meta-analysis included family-focused in-
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terventions (n = 7), making it difﬁ cult to disentangle the 
effects of group therapy and family involvement. Though 
Muris et al.  [38] have recently demonstrated the similar-
ity in outcomes of group and individual treatment with-
out parental involvement in either condition, future re-
search should continue to investigate this question while 
controlling the overlap of family-focused and group treat-
ment settings. 
 Weisz et al.  [9, 10] and Kazdin et al.  [49] reported in 
their meta-analyses that only around one third of all pub-
lished treatment outcome studies reported data from fol-
low-up assessments. Recently published studies seem to 
have improved in this regard, as 16 (66.7%) of the 24 out-
come studies included in our meta-analysis reported fol-
low-up data. In our meta-analysis, the mean pre-follow-
up effect size was 1.36, suggesting that treatment gains 
were well maintained. Furthermore, 72% of the children 
did not meet the criteria for their principal pretreatment 
diagnosis at follow-up. These results are consistent with 
three long-term follow-up studies  [40–42] , which have 
demonstrated that the effects of child anxiety treatments 
are relatively stable and long-lasting (up to 7.4 years). 
 With the exception of ﬁ ve studies that investigated the 
efﬁ cacy of psychotherapy for social phobia  [32, 33, 46, 
50, 51] , none of the other treatment studies differentiated 
between the different types of anxiety disorders. In fact, 
these studies tested general treatments for anxiety disor-
ders in groups of children with different anxiety disorders 
(separation anxiety disorder, generalized anxiety disor-
der, speciﬁ c phobia, social phobia). However, RCT stud-
ies with a focus on speciﬁ c anxiety disorders, in particular 
separation anxiety disorder, generalized anxiety disorder 
and speciﬁ c phobia, are needed to complement the previ-
ous global approaches. 
 All studies included in the meta-analysis investigated 
the efﬁ cacy of CBT. Thus, non-CBT outcome studies that 
fulﬁ ll the methodological criteria required by CONSORT 
are still missing. In the literature search for the present 
study, we found a chart review of child psychoanalysis 
and psychotherapy of children with emotional disorders 
 [18] , which reported an improvement rate of 47.2% in a 
large child sample (n = 352). However, this study did not 
meet the inclusion criteria for our meta-analysis (see Ap-
pendix 2). 
 It has to be considered that the studies included in this 
meta-analysis demonstrate efﬁ cacy of psychotherapy for 
anxious children; however, effectiveness has to be prov-
en. Therefore, now that CBT trials are found to be suc-
cessful, it is important to extend studies to the clinical 
settings. Baer and Garland  [32] investigated a pilot study 
of community-based cognitive-behavioral group therapy 
for adolescents with social phobia. Although the sample 
size (n = 12) was small, the study provides support for the 
use of simpliﬁ ed cognitive-behavioral interventions in 
community psychiatric settings. Similar conclusions can 
be drawn from the study of Ginsburg and Drake  [31] that 
evaluated the feasibility and effectiveness of a school-
based group treatment for anxiety disorders with African-
American adolescents. For the evaluation of the present-
ed results, general limitations regarding meta-analyses 
have to be considered. The reported effect sizes only pro-
vide information about how much the patients improved 
after therapy compared to their values before therapy. 
Thus, the effect sizes do not provide information regard-
ing symptom severity and functional level after therapy 
compared to healthy control participants. 
 Reported effect sizes are based entirely on self-report 
measures, due to the fact that parent and teacher reports 
were not regularly assessed. However, the gold standard 
in assessing efﬁ cacy of psychotherapy in children and ad-
olescents should be the inclusion of self-reports as well as 
parent and teacher reports  [71] . Further psychotherapy 
research should take this into consideration in order to 
get a sound and accurate description of therapy out-
come. 
 Knowing how to treat childhood anxiety disorders is 
important. Such knowledge both helps ease the suffering 
of children and contributes to the reduction and preven-
tion of future suffering as adults. As we work toward im-
proving psychotherapy for childhood anxiety disorders, 
we must especially focus on helping those children for 
whom existing therapies continue to produce less than 
optimal outcomes. 
 Acknowledgements 
 This research was supported by a Swiss National Science Foun-
dation scholarship to Tina In-Albon (PBBS1-102350) and by a 
grant of the Swiss National Science Foundation to Silvia Schneider 
(SNF PP001-68701). The authors thank David A. Moscovitch, Mi-
chael K. Suvak, Department of Psychology, Boston University, and 
Andrea H. Meyer, University of Basel. 
D
ow
nl
oa
de
d 
by
: 
Un
ive
rs
itä
ts
bi
bl
io
th
ek
 M
ed
izi
n 
Ba
se
l  
   
   
   
   
   
  
13
1.
15
2.
21
1.
61
 - 
10
/2
5/
20
17
 8
:0
0:
05
 A
M
 In-Albon/Schneider
 
 Psychother Psychosom 2007;76:15–24 22
Appendix 1
Studies Included in the Meta-Analysis
Study n Age Mode Diagnosis Weeks Com-
pleted, %
FU Pre-/post-treatment effect size  (d) 
per treatment condition4 
Baer and Garland 
[32] 12 13–18 Gr1 SoP 12 36 – SPAI: 1.20
Barrett et al. [43] 79 7–14 Ind1, 2 SAD, OAD, SoP 12 94 6, 12 months; Barrett
et al. [40]: 6 years
CBT: 0.59, CBT+Fam: 0.89
Barrett [48] 60 7–14 Gr1, 2 SAD, OAD, SoP 12 83 12 months FSSC-R Ch: 1.54, FSSC-R Fam: 
2.37
Beidel et al. [33] 67 8–12 Gr1, 3 SoP 12 75 6 months SPAI: 1.21; SPAI Tb: 0.18
Cobham et al. [44] 67 7–14 Ind, 
act tx1, 2
SAD, OAD, GAD, SPP, SoP 10 91 6, 12 months CBT Ch anx: 0.77, CBT+PAM Ch 
anx: 0.49, CBT+PAM Ch+Pa anx: 
0.40, CBT Ch+Pa anx: 0.66
Flannery-Schröder 
et al. [52] 37 8–14 Ind+Gr1 GAD, SAD, SoP 18 76 3 months Ind: 1.26, Gr: 0.73
Gallagher et al. [51] 23 8–11 Gr1 SoP 3 50 3 weeks 0.36
Ginsburg et al. [31] 12 14–17 Gr1 GAD, SPP, AG, SoP 10 75 – SCARED: 0.27
Hayward et al. [50] 35 14–18 Gr1 SoP 16 81 12 months SPAI: 1.10
Heyne et al. [45] 61 7–14 Ind, act tx1, 2 SAD, SoP, GAD, PD, OCD, 
CD
8 – 4.5 months Ch: 0.51, Pa+Te: 1.58, Ch+Pa+Te: 
0.78
Kendall [53] 47 9–13 Ind1 SAD, OAD, AD 16 78 12 months; Kendall 
and Southam-Gerow 
[41]: 3.4 years
1.32
Kendall et al. [54] 94 9–13 Ind1 SAD, OAD, AD 16 80 12 months; Kendall
et al. [42]: 7 years
1.08
King et al. [55] 34 5–15 Ind 2 SAD, OAD, SoP, SPP, CD 4 100 3 months 1.37
Last et al. [34] 56 6–17 Ind2, 3 Schoolpho4 12 73 1 month STAIC-T CBT: 0.57, STAIC-T ES: 
1.33
Manassis et al. [37] 78 8–12 Ind+Gr2 GAD, SAD, SPP, SoP, PD 12 – – SASC Gr: 0.21, SASC Ind: 0.43
Mendlowitz et al. 
[39] 62 7–12 Gr, act tx1, 2 – 12 91 – Ch: 0.26, Pa: 0, Ch+Pa: 0.33
Muris et al. [38] 36 8–13 Gr+Ind1 GAD, SAD, SoP 12 100 – STAIC Ind: 0.82, STAIC Gr: 1.08
Muris et al. [36] 30 9–12 Gr1, 3 GAD, SAD, SoP 12 80 – STAIC: 1.38
Nauta et al. [47] 79 7–18 Ind1, 2 SAD, SoP, GAD, PD 12 96 3 months SCAS Ch: 1.13, SCAS Pa: 0.65
Rapee [56] 95 7–16 Gr2 SAD, GAD, SoP 12 – 12 months 0.81
Silverman et al. [69] 56 6–16 Gr2 OAD, SoP, GAD – 73 3, 6, 12 months 0.64
Silverman et al. [35] 81 6–16 Ind2, 3 SPP, SoP, AG 10 78 3, 6, 12 months SC: 0.91, CM: 0.57, ES: 0.27
Spence et al. [46] 50 7–14 Gr, act tx1, 2 SoP – – 6, 12 months Ch: 0.97, Ch+Pa: 0.75
Toren et al. [57] 24 6–13 Gr2 SAD, OAD 10 – 12, 36 months 0.58
SAD = Separation anxiety disorder; GAD = generalized anxiety disorder; OAD = overanxiety disorder; SoP = social phobia; SPP = speciﬁ c phobia; PD = 
panic disorder; AG = agoraphobia; CD = conduct disorder; Schoolpho = school refusal; Gr = group treatment; Ind = individual treatment; act tx = active pla-
cebo treatment; SPAI = Social Phobia and Anxiety Inventory; SCARED = Screen for Childhood Anxiety Related Emotional Disorders; SCAS = Spence Child 
Anxiety Scale; STAIC-T = State-Trait Anxiety Inventory for Children; SASC = Social Anxiety Scale for Children; ES = education support; SC = exposure-based 
cognitive self-control; CM = exposure-based contingency management; PAM = parental anxiety management; Tb = testbuster.
1 Child-focused treatment.
2 Family-focused treatment. 
3 Attention-placebo control group.
4 Effect sizes are indicated for outcome measure RCMAS, when not otherwise speciﬁ ed.
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